Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View

Table 3

Ongoing treatment studies evaluating EGFR MoAbs in cervical cancer patients.

Protocol number	Disease stage	Target therapy	Adjuvant treatment	Study phase	PI
NCT00803062	Stage IVb/	Bevacizumab	Cisplatin/topotecan hydrochloride/paclitaxel	Phase III	Krishnansu Tewari, MD
	recurrent/persistent
NCT00548418	Recurrent/Persistent	Bevacizumab	Topotecan/cisplatin	Phase II	Janet S Rader, MD